Literature DB >> 10968708

Recent advances in the application of immunohistochemical markers for the diagnosis of soft tissue tumors.

S Suster1.   

Abstract

Soft tissue tumors represent a frequent source of diagnostic difficulty for surgical pathologists. Over the past 20 years, immunohistochemical studies have emerged as a powerful and helpful tool for the assessment and characterization of these lesions. Although much progress has been made in this field, the continuous realization of the relative lack of specificity and broad overlap in reactivity for the various tumor markers among these lesions has contributed to limit somewhat their usefulness and reliability in this area of tumor diagnosis. However, with the advent of new markers has come the new promise of better and more accurate distinction and characterization for these tumors. Herein we will review the current status of immunohistochemical tumor markers in the diagnosis of soft tissue neoplasms and address some of the more recently described antibodies and their relative value and limitations for the diagnosis of these tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968708

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  "Cutaneous-type" angiosarcoma arising in a mature cystic teratoma of the ovary.

Authors:  M A den Bakker; A C Ansink; P C Ewing-Graham
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

2.  Expression of smooth muscle markers in so called malignant fibrous histiocytomas.

Authors:  T Hasegawa; F Hasegawa; T Hirose; T Sano; Y Matsuno
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

3.  Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis.

Authors:  José A Jiménez-Heffernan; Abelardo Aguilera; Luiz S Aroeira; Enrique Lara-Pezzi; M Auxiliadora Bajo; Gloria del Peso; Marta Ramírez; Carlos Gamallo; José A Sánchez-Tomero; Vicente Alvarez; Manuel López-Cabrera; Rafael Selgas
Journal:  Virchows Arch       Date:  2004-01-29       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.